HECTD2 and cancer: Cross‐referencing these results with the cancer genome atlas–liver hepatocellular carcinoma database (Figure S1C,D, Supporting Information), revealed that HECTD2 was among the top ten upregulated proteins in lenvatinib‐resistant HCC cells (Figure 1E).